Poly‐GP in cerebrospinal fluid links C9orf72‐associated dipeptide repeat expression to the asymptomatic phase of ALS/FTD
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The C9orf72 GGGGCC repeat expansion is a major cause of amyotrophic lateral sclerosis and frontotemporal dementia (c9ALS/FTD).Non-conventional repeat translation results in five dipeptide repeat proteins (DPRs), but their clinical utility, overall significance, and temporal course in the pathogenesis of c9ALS/FTD are unclear, although animal models support a gain-of-function mechanism.Here, we established a poly-GP immunoassay from cerebrospinal fluid (CSF) to identify and characterize C9orf72 patients.Significant poly-GP levels were already detectable in asymptomatic C9orf72 mutation carriers compared to healthy controls and patients with other neurodegenerative diseases.The poly-GP levels in asymptomatic carriers were similar to symptomatic c9ALS/FTD cases.Poly-GP levels were not correlated with disease onset, clinical scores, and CSF levels of neurofilaments as a marker for axonal damage.Poly-GP determination in CSF revealed a C9orf72 mutation carrier in our cohort and may thus be used as a diagnostic marker in addition to genetic testing to screen patients.Presymptomatic expression of poly-GP and likely other DPR species may contribute to disease onset and thus represents an alluring therapeutic target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In C9orf72 expansion carriers, poly(GP), one of the DPR proteins produced by the C9orf72 expansions, is elevated as early as the presymptomatic phase.”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [109]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeJesus-Hernandez, M., Mackenzie, I. R., Boeve, B. F., Boxer, A. L., Baker, M., Rutherford, N. J., Nicholson, A. M., Finch, N. A., Flynn, H., Adamson, J., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.09.011 · Cited by 4,936 · cited 1×
“Formation of repeat RNA foci in the nucleus and the accompanying sequestration of RNA-binding proteins are thought to alter RNA processing (DeJesus-Hernandez et al, 2011).”
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 1×
“Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are neurodegenerative diseases with similar neuropathological features and overlapping clinical symptoms and pathomechanisms (Ling et al, 2013).”
State of play in amyotrophic lateral sclerosis genetics
Renton, A. E., Chiò, A., & Traynor, B. J. (2014) · Nature Neuroscience · doi:10.1038/nn.3584 · Cited by 1,544
The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS
Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H. A., Cruts, M., Van Broeckhoven, C., et al. (2013) · Science · doi:10.1126/science.1232927 · Cited by 1,277
Self-citationAsh, P. E. A., Bieniek, K. F., Gendron, T. F., Caulfield, T., Lin, W.-L., DeJesus-Hernandez, M., van Blitterswijk, M. M., Jansen-West, K., Paul, J. W., Rademakers, R., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.004 · Cited by 1,100
Non-ATG–initiated translation directed by microsatellite expansions
Zu, T., Gibbens, B., Doty, N. S., Gomes-Pereira, M., Huguet, A., Stone, M. D., Margolis, J., Peterson, M., Markowski, T. W., Ingram, M. A. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013343108 · Cited by 903
RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
Zu, T., Liu, Y., Bañez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T. M., Harms, M. B., Falchook, A. E., Subramony, S. H., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315438110 · Cited by 760
C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C. E., Clayton, E. L., Devoy, A., Moens, T., Norona, F. E., Woollacott, I. O. C., Pietrzyk, J., et al. (2014) · Science · doi:10.1126/science.1256800 · Cited by 740 · cited 2×
“Since poly-GR/PR and poly-GA are by far more toxic than polyGP in cellular and animal models (Mizielinska et al, 2014), it will be critical to determine their levels during disease progression to better address the role of DPRs in c9ALS/FTD pathogenesis.”
Jovičić, A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S. B., Paul, J. W., Sun, S., Herdy, J. R., Bieri, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4085 · Cited by 598
Gendron, T. F., Bieniek, K. F., Zhang, Y.-J., Jansen-West, K., Ash, P. E. A., Caulfield, T., Daughrity, L., Dunmore, J. H., Castanedes-Casey, M., Chew, J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1192-8 · Cited by 581
C9orf72 is required for proper macrophage and microglial function in mice
O’Rourke, J. G., Bogdanik, L., Yáñez, A., Lall, D., Wolf, A. J., Muhammad, A. K. M. G., Ho, R., Carmona, S., Vit, J. P., Zarrow, J., et al. (2016) · Science · doi:10.1126/science.aaf1064 · Cited by 550
Rohrer, J. D., Nicholas, J. M., Cash, D. M., van Swieten, J., Dopper, E., Jiskoot, L., van Minkelen, R., Rombouts, S. A., Cardoso, M. J., Clegg, S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70324-2 · Cited by 538
Jiang, J., Zhu, Q., Gendron, T. F., Saberi, S., McAlonis-Downes, M., Seelman, A., Stauffer, J. E., Jafar-nejad, P., Drenner, K., Schulte, D., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.006 · Cited by 536 · cited 3×
“While C9orf72 knockout mice show no neurodegeneration, repeat expressing mice develop neuron loss and TDP-43 pathology depending on the expression levels (Hayes & Rothstein, 2016; Jiang et al, 2016; O’Rourke et al, 2016).”
Self-citationMori, K., Arzberger, T., Grässer, F. A., Gijselinck, I., May, S., Rentzsch, K., Weng, S.-M., Schludi, M. H., van der Zee, J., Cruts, M., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1189-3 · Cited by 496
Self-citationAl-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0911-2 · Cited by 475
Sellier, C., Campanari, M., Julie Corbier, C., Gaucherot, A., Kolb‐Cheynel, I., Oulad‐Abdelghani, M., Ruffenach, F., Page, A., Ciura, S., Kabashi, E., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593350 · Cited by 414
C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits
Chew, J., Gendron, T. F., Prudencio, M., Sasaguri, H., Zhang, Y.-J., Castanedes-Casey, M., Lee, C. W., Jansen-West, K., Kurti, A., Murray, M. E., et al. (2015) · Science · doi:10.1126/science.aaa9344 · Cited by 409
Self-citationC9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
Liu, Y., Pattamatta, A., Zu, T., Reid, T., Bardhi, O., Borchelt, D. R., Yachnis, A. T., & Ranum, L. P. W. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.005 · Cited by 374
Su, Z., Zhang, Y., Gendron, T. F., Bauer, P. O., Chew, J., Yang, W.-Y., Fostvedt, E., Jansen-West, K., Belzil, V. V., Desaro, P., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.041 · Cited by 356
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345
Self-citationBeck, J., Poulter, M., Hensman, D., Rohrer, J. D., Mahoney, C. J., Adamson, G., Campbell, T., Uphill, J., Borg, A., Fratta, P., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.01.011 · Cited by 345 · cited 1×
“The repeat expansion in C9orf72 patients seems to vary mostly between 400 and > 5,000 (GGGGCC)n repeats (Beck et al, 2013; Fratta et al, 2013) and is notoriously difficult to determine precisely (Akimoto et al, 2014).”
Zhang, Y.-J., Jansen-West, K., Xu, Y.-F., Gendron, T. F., Bieniek, K. F., Lin, W.-L., Sasaguri, H., Caulfield, T., Hubbard, J., Daughrity, L., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1336-5 · Cited by 337
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Steinacker, P., Feneberg, E., Weishaupt, J., Brettschneider, J., Tumani, H., Andersen, P. M., von Arnim, C. A. F., Böhm, S., Kassubek, J., Kubisch, C., et al. (2015) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2015-311387 · Cited by 317
Self-citationMay, S., Hornburg, D., Schludi, M. H., Arzberger, T., Rentzsch, K., Schwenk, B. M., Grässer, F. A., Mori, K., Kremmer, E., Banzhaf-Strathmann, J., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1329-4 · Cited by 312
Self-citationKobayashi, H., Abe, K., Matsuura, T., Ikeda, Y., Hitomi, T., Akechi, Y., Habu, T., Liu, W., Okuda, H., & Koizumi, A. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.015 · Cited by 287
Mosaicism in health and disease — clones picking up speed
Forsberg, L. A., Gisselsson, D., & Dumanski, J. P. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.145 · Cited by 263
Mackenzie, I. R. A., Frick, P., Grässer, F. A., Gendron, T. F., Petrucelli, L., Cashman, N. R., Edbauer, D., Kremmer, E., Prudlo, J., Troost, D., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1476-2 · Cited by 231 · cited 1×
“Although the total DPR levels vary between patients, we are not aware of cases with vastly different ratios of the different DPR species (Mackenzie et al, 2015; Schludi et al, 2015).”
Self-citationWeydt, P., Oeckl, P., Huss, A., Müller, K., Volk, A. E., Kuhle, J., Knehr, A., Andersen, P. M., Prudlo, J., Steinacker, P., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24552 · Cited by 218
Self-citationCell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD
Westergard, T., Jensen, B. K., Wen, X., Cai, J., Kropf, E., Iacovitti, L., Pasinelli, P., & Trotti, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.032 · Cited by 202
German Consortium for Frontotemporal Lobar Degeneration, Schludi, M. H., Bavarian Brain Banking Alliance, May, S., Grässer, F. A., Rentzsch, K., Kremmer, E., Küpper, C., Klopstock, T., Arzberger, T., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1450-z · Cited by 186
Self-citationVatsavayai, S. C., Yoon, S. J., Gardner, R. C., Gendron, T. F., Vargas, J. N. S., Trujillo, A., Pribadi, M., Phillips, J. J., Gaus, S. E., Hixson, J. D., et al. (2016) · Brain · doi:10.1093/brain/aww250 · Cited by 171
Homozygosity for the C9orf72 GGGGCC repeat expansion in frontotemporal dementia
Fratta, P., Poulter, M., Lashley, T., Rohrer, J. D., Polke, J. M., Beck, J., Ryan, N., Hensman, D., Mizielinska, S., Waite, A. J., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1147-0 · Cited by 137
Akimoto, C., Volk, A. E., van Blitterswijk, M., Van den Broeck, M., Leblond, C. S., Lumbroso, S., Camu, W., Neitzel, B., Onodera, O., van Rheenen, W., et al. (2014) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2014-102360 · Cited by 131
Self-citationNordin, A., Akimoto, C., Wuolikainen, A., Alstermark, H., Jonsson, P., Birve, A., Marklund, S. L., Graffmo, K. S., Forsberg, K., Brännström, T., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv064 · Cited by 119
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease
Steinacker, P., Blennow, K., Halbgebauer, S., Shi, S., Ruf, V., Oeckl, P., Giese, A., Kuhle, J., Slivarichova, D., Zetterberg, H., et al. (2016) · Scientific Reports · doi:10.1038/srep38737 · Cited by 110
Self-citationProudfoot, M. J., Gutowski, N. J., Edbauer, D., Hilton, D. A., Stephens, M., Rankin, J., & Mackenzie, I. R. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1245-7 · Cited by 85
Self-citationKonsortium zur Erforschung der frontotemporalen Lobärdegeneration
Otto, M., Ludolph, A. C., Landwehrmeyer, G. B., Förstl, H., Diehl‐Schmid, J., Neumann, M., Kretzschmar, H. A., Schroeter, M., Kornhuber, J., & Danek, A. (2011) · Der Nervenarzt · doi:10.1007/s00115-011-3261-3 · Cited by 75
Self-citationBaborie, A., Griffiths, T. D., Jaros, E., Perry, R., McKeith, I. G., Burn, D. J., Masuda‐Suzukake, M., Hasegawa, M., Rollinson, S., Pickering‐Brown, S., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12178 · Cited by 70
ALS and FTD: an epigenetic perspective
Belzil, V. V., Katzman, R. B., & Petrucelli, L. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1587-4 · Cited by 69
An amyloid-like cascade hypothesis for C9orf72 ALS/FTD
Edbauer, D., & Haass, C. (2016) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2015.10.009 · Cited by 65
Self-citationC9ORF72 -ALS/FTD: Transgenic Mice Make a Come-BAC
Hayes, L. R., & Rothstein, J. D. (2016) · Neuron · doi:10.1016/j.neuron.2016.04.026 · Cited by 17
Cited by
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Self-citationC9orf72-mediated ALS and FTD: multiple pathways to disease
Balendra, R., & Isaacs, A. M. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0047-2 · Cited by 715
An update on genetic frontotemporal dementia
Greaves, C. V., & Rohrer, J. D. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09363-4 · Cited by 500
(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00009-9 · Cited by 421
Frontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Metadata
- Authors
- Lehmer, C., Oeckl, P., Weishaupt, J. H., Volk, A. E., Diehl‐Schmid, J., Schroeter, M. L., Lauer, M., Kornhuber, J., Levin, J., Fassbender, K., Landwehrmeyer, B., German Consortium for Frontotemporal Lobar Degeneration, Schludi, M. H., Arzberger, T., Kremmer, E., Flatley, A., Feederle, R., Steinacker, P., Weydt, P., Ludolph, A. C., Edbauer, D., Otto, M., Danek, A., Feneberg, E., Anderl‐Straub, S., von Arnim, C., Jahn, H., Schneider, A., Maler, M., Polyakova, M., Riedl, L., Wiltfang, J., & Ziegler, G.
- Affiliations
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Ulm (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- Technical University of Munich (DE)
- University Hospital Leipzig (DE)
- Universitätsklinikum Würzburg (DE)
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- Saarland University (DE)
- Helmholtz Munich (DE)
- University Hospital Bonn (DE)
- Corresponding author
- Edbauer, Dieter
- Otto, Markus
- ORCID
- Oeckl, Patrick
- Weishaupt, Jochen H
- Volk, Alexander E
- Diehl‐Schmid, Janine
- Schroeter, Matthias L
- Lauer, Martin
- Kornhuber, Johannes
- Levin, Johannes
- Fassbender, Klaus
- Kremmer, Elisabeth
- Flatley, Andrew
- Feederle, Regina
- Steinacker, Petra
- Weydt, Patrick
- Ludolph, Albert C
- Edbauer, Dieter
- Otto, Markus
- Danek, Adrian
- Feneberg, Emily
- Jahn, Holger
- Schneider, Anja
- Wiltfang, Jens
- Ziegler, Georg
- Venue
- EMBO Molecular Medicine
- Published
- 2017-04-13
- Volume
- 9
- Issue
- 7
- Pages
- 859-868
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- PMC
- PMC5494528
- OpenAlex
- W2606980242
- Cited by
- 118
- References
- 41
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 13 · 2023: 17 · 2022: 17 · 2021: 9 · 2020: 11 · 2019: 15 · 2018: 19 · 2017: 4
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- other-oa
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- EMBO Molecular Medicine (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Site cant be reached (submittedVersion, cc-by)
- DZNE Pub (submittedVersion, other-oa)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- JPND Networks SOPHIA (01ED1202A)
- BiomarkAPD (01ED1203F)
- PreFrontAls (01ED1512)
- STRENGTH (01ED1408)
- EU (246513, 633190, 617198)
- German Research Foundation/DFG (VO2028)
- Baden‐Württemberg (D.3830)
- BIU (D.5009)
- Charcot Foundation
- NOMIS Foundation
- Seventh Framework Programme (617198)
- Bundesministerium für Bildung und Forschung (O1GI1007A, 01GM1103A)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Hereditary Neurological Disorders
- Keywords
- C9orf72, GGGGCC repeat expansion, dipeptide repeat proteins, cerebrospinal fluid biomarkers, amyotrophic lateral sclerosis, frontotemporal dementia, presymptomatic carriers, gain-of-function mechanism, disease onset, neurofilaments, immunoassay
- MeSH terms
- C9orf72 Protein, Amyotrophic Lateral Sclerosis, Cerebrospinal Fluid, Cross-Sectional Studies, Dipeptides, Humans, Immunoassay, Peptides, Biomarkers, Gene Expression, Repetitive Sequences, Amino Acid, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.